Abbott’s Selloff Puts Earnings Growth Under Scrutiny
Abbott’s 2026 decline has sharpened questions about whether its sales growth and earnings outlook justify its valuation.
Stocks
Markets, companies and the economy, from New York and Frankfurt to Istanbul and Tokyo.
Page 55 of 89
Abbott’s 2026 decline has sharpened questions about whether its sales growth and earnings outlook justify its valuation.
Stocks
Yahoo Finance’s Brian Sozzi points to steep valuation multiples as CrowdStrike shares rise and investors anticipate stronger demand.
Stocks
The company reported higher first-half gross profit and lower losses and operating cash use as its shares returned to Nasdaq.
Stocks
Nokia shares rose 16.2% over six months as AI and cloud demand lifted orders, while estimates for 2027 declined.
Stocks
Centene lifted its 2026 earnings outlook, while nonrecurring benefits and shrinking membership leave questions about sustaining margins.
Stocks
The list includes Nike and PayPal, whose results and business pressures illustrate the challenges behind the stocks’ distance from record highs.
Stocks
StockStory highlighted five-year sales growth and robust cash generation, while pointing to a comparatively low return on invested capital.
Stocks
The publisher pointed to stagnant organic revenue and a 6.9% average return on invested capital in its cautious assessment of the company.
Stocks
The publisher cited weak long-term revenue growth, operating losses and cash use while assessing Stratasys after its second-quarter results.
Stocks
The publisher points to five years of flat revenue, a narrower operating margin and declining earnings per share in its assessment of Hayward.
Stocks
The publisher cited slower admissions growth, falling per-share earnings and lower returns as reasons for its cautious view of Acadia Healthcare.
Stocks
The publisher cites weaker revenue expectations and declines in operating and cash-flow margins, despite United Therapeutics’ past revenue growth.
Stocks
The publisher points to weaker recent revenue and earnings trends as it argues Main Street Capital falls short of its quality test.
Stocks
The publisher pointed to modest sales and earnings growth, plus a forward valuation it said leaves limited room for upside.
Stocks
The publisher points to strong margins but flags flat sales, while Altria shares trade above the price cited in its analysis.
Stocks
The publisher cited modest revenue growth, a flat store count and low returns on invested capital in its assessment of AEO.
Stocks
StockStory highlights rising subscriptions and customer spending at LegalZoom, while pointing to modest revenue growth over three years.
Stocks
StockStory points to passenger-mile growth, declining returns and leverage as reasons for caution on the airline.
Stocks
ClearBridge added the game publisher in the third quarter, citing the forthcoming release as a potential driver of sales and earnings.
Stocks
The investment manager cited recurring aftermarket revenue and exposure to automation, energy efficiency and data center infrastructure.
Stocks
StockStory cites stronger per-share earnings and rising returns on capital, but analysts expect Brink's revenue growth to slow.
Stocks
ClearBridge said Grainger detracted from its strategy as weaker sentiment toward cyclical industrials pressured the stock despite a beat-and-raise quarter.
Stocks
The growth strategy cited its Microsoft underweight as a drag, even as Azure momentum and Copilot usage supported the shares.
Stocks
The strategy cited strong execution, new customer growth and raised full-year guidance as positive signs for Arista Networks.
Stocks